BRCA study aims to unlock cancer secrets

NCT ID NCT01034033

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects tumor and blood samples from 3,300 people at high genetic risk for breast, ovarian, and related cancers. Researchers want to learn how these cancers develop and how well treatments work. Participants include those with BRCA1/2 or other gene mutations, or a strong family history of these cancers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could improve understanding of how these cancers develop and help identify better treatments for people with BRCA mutations.
What could go wrong
This is an observational study, not a treatment trial. It may not directly lead to new therapies, and results depend on long-term data collection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Stanford University School of Medicine

    RECRUITING

    Stanford, California, 94305, United States

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.